March 1 (Reuters) - Paratek Pharmaceuticals Inc:
* PARATEK PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND REMAINS ON TRACK FOR COMMERCIAL LAUNCH BY FIRST QUARTER 2019
* Q4 EARNINGS PER SHARE VIEW $-0.75 -- THOMSON REUTERS I/B/E/S
* AS OF DECEMBER 31, 2017, PARATEK HAD CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $151.7 MILLION Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)
